AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

COR · NYSE · Medical - Distribution

Cencora (COR)

Distributes pharmaceuticals and provides specialty-practice, logistics and manufacturer services worldwide.

$318.03

vs last close+3.60 (+1.14%)

In millions of USD, except per-share figures

In millions	Q4 FY23Sep 2023	Q1 FY24Dec 2023	Q2 FY24Mar 2024	Q3 FY24Jun 2024	Q4 FY24Sep 2024	Q1 FY25Dec 2024	Q2 FY25Mar 2025	Q3 FY25Jun 2025	Q4 FY25Sep 2025	Q1 FY26Dec 2025	Q2 FY26Mar 2026	Q3 FY26Jun 2026
Revenue	68,922	72,253	68,414	74,241	79,050	81,487	75,454	80,664	83,729	85,932	78,356	84,755
Cost of revenue	67,016	70,103	66,157	72,155	76,887	79,223	72,838	78,005	81,125	83,120	75,033	81,148
Gross profit	1,907	2,150	2,258	2,087	2,163	2,264	2,616	2,658	2,603	2,812	3,323	3,607
	1,394	1,399	1,389	1,383	1,490	1,472	1,600	1,673	1,749	1,795	1,978	2,487
Selling, general & administrative	1,394	1,399	1,389	1,383	1,490	1,472	1,600	1,673	1,749	1,795	1,978	2,132
Other expenses	0	0	0	0	0	0	0	0	0	0	0	355
Operating income	513	751	869	703	673	792	1,016	986	855	1,016	1,345	1,120
	−66	32	−402	−75	−548	−171	−87	−89	−1,042	−308	744	−124
Interest income	13	18	13	28	33	33	28	35	32	21	14	0
Interest expense	74	59	77	59	54	61	132	117	109	93	154	141
Other non-operating income	−8	−91	325	16	493	110	−45	−28	932	235	−898	−17
Income before tax	446	783	467	628	125	620	929	896	−187	709	2,089	996
Income tax expense	97	180	46	141	118	127	211	207	146	143	459	220
Net income from continuing operations	349	603	421	488	7	494	717	690	−333	566	1,630	777
Net income	351	602	421	483	3	489	718	687	−340	560	1,641	764
EPS, basic	$1.74	$3.01	$2.11	$2.44	$0.02	$2.52	$3.70	$3.55	−$1.75	$2.88	$8.44	$3.95
EPS, diluted	$1.72	$2.98	$2.09	$2.42	$0.02	$2.50	$3.68	$3.52	−$1.75	$2.87	$8.40	$3.94
Weighted average shares, basic	203	202	199	198	199	194	194	194	194	194	195	193
Weighted average shares, diluted	203	202	201	200	200	195	195	195	194	195	195	194
EBITDA	797	1,119	822	966	458	961	1,323	1,269	183	1,041	2,502	1,407
Depreciation & amortization	276	277	278	279	278	279	262	256	261	260	259	269
EBIT	521	842	544	687	179	682	1,061	1,013	−78	781	2,243	1,137